Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834625 | 0.87 | ALDH1A1 (0.32) | ALDH1A1TSHRTDP1 | |
| SCHEMBL12304992 | 0.86 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL64765 | 0.85 | — | — | |
| SCHEMBL18974716 | 0.84 | — | — | |
| SCHEMBL22039632 | 0.84 | ALDH1A1 (0.36) | ALDH1A1TSHRTDP1 | |
| SCHEMBL11210505 | 0.84 | ALDH1A1 (0.30) | ALDH1A1TSHRTDP1 | |
| Ethylene Glycol SCHEMBL28232976 | 0.83 | ALDH1A1 (0.43) | ALDH1A1TSHRTDP1 | |
| Water SCHEMBL27934281 | 0.83 | ALDH1A1 (0.43) | ALDH1A1TSHRTDP1 | |
| SCHEMBL2591293 | 0.83 | — | — | |
| Methoxymethane SCHEMBL1476203 | 0.83 | ALDH1A1 (0.43) | ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170183419-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2017-06-29 | — | — | US | disclosed |
| US-8945513-B2 | Star polymer nanoshells and methods of preparation thereof | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-02-03 | — | — | US | disclosed |
| US-8802667-B2 | Benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2014-08-12 | — | — | US | disclosed |
| US-20130302357-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20120237447-A1 | STAR POLYMER NANOSHELLS AND METHODS OF PREPARATION THEREOF | SAN JOSE STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2012-09-20 | — | — | US | disclosed |
| EP-1962959-B1 | NEUROPEPTIDE-2 RECEPTOR-AGONISTS | HOFFMANN LA ROCHE (CH) | 2012-03-14 | — | — | EP | disclosed |
| WO-2007065808-A2 | NEUROPEPTIDE-2 RECEPTOR-AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-06-14 | — | — | WO | disclosed |
| US-4381416-A | Process for producing isoprene | KURARAY CO., LTD. (JP) | 1983-04-26 | — | — | US | disclosed |
| EP-0030109-A1 | Process for producing isoprene | KURARAY CO., LTD. (JP) | 1981-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120237447-A1 | STAR POLYMER NANOSHELLS AND METHODS OF PREPARATION THEREOF | VCL, CD47, MSN | ALDH1A1 4870/4885TSHR 3436/4885TDP1 3746/4885 |
| US-20170183419-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | GABRB1, GABRB3, GABRA1 | ALDH1A1 619/4885TSHR 707/4885TDP1 3601/4885 |
| US-20130302357-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | GABRB1, GABRB3, GABRA1 | ALDH1A1 619/4885TSHR 707/4885TDP1 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.